147 related articles for article (PubMed ID: 16763012)
21. Effects of glucose supplementation on the pharmacokinetics of intravenous chlorzoxazone in rats with water deprivation for 72 h.
Kim YC; Lee I; Kim SG; Ko SH; Lee MG; Kim SH
Life Sci; 2006 Nov; 79(23):2179-86. PubMed ID: 16914164
[TBL] [Abstract][Full Text] [Related]
22. Chlorzoxazone metabolism by winter flounder liver microsomes: evidence for existence of a CYP2E1-like isoform in teleosts.
Wall KL; Crivello J
Toxicol Appl Pharmacol; 1998 Jul; 151(1):98-104. PubMed ID: 9705891
[TBL] [Abstract][Full Text] [Related]
23. Comparison of cytochrome P4502E1 (CYP2E1) activity and hepatic and lymphocyte mRNA expression in patients with chronic hepatitis C.
Haufroid V; Ligocka D; Wallemacq P; Lison D; Horsmans Y
Toxicol Lett; 2005 Jan; 155(1):171-7. PubMed ID: 15585372
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of chlorzoxazone in rats with diabetes: Induction of CYP2E1 on 6-hydroxychlorzoxazone formation.
Baek HW; Bae SK; Lee MG; Sohn YT
J Pharm Sci; 2006 Nov; 95(11):2452-62. PubMed ID: 16886191
[TBL] [Abstract][Full Text] [Related]
25. Human hepatic alcohol dehydrogenase and human erythrocyte catalase do not metabolize the cytochrome P-4502E1 substrate, chlorzoxazone.
McCarver-May DG; Durisin L
Alcohol Clin Exp Res; 1996 May; 20(3):533-7. PubMed ID: 8727250
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress.
Leclercq I; Desager JP; Horsmans Y
Clin Pharmacol Ther; 1998 Aug; 64(2):144-9. PubMed ID: 9728894
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of intravenous chlorzoxazone in rats with dehydration and rehydration: effects of food intakes.
Kim YC; Kim YG; Kim EJ; Cho MK; Kim SG; Lee MG
Biopharm Drug Dispos; 2003 Mar; 24(2):53-61. PubMed ID: 12619050
[TBL] [Abstract][Full Text] [Related]
28. Phenobarbital increases monkey in vivo nicotine disposition and induces liver and brain CYP2B6 protein.
Lee AM; Miksys S; Tyndale RF
Br J Pharmacol; 2006 Jul; 148(6):786-94. PubMed ID: 16751792
[TBL] [Abstract][Full Text] [Related]
29. Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans.
Lucas D; Ferrara R; Gonzalez E; Bodenez P; Albores A; Manno M; Berthou F
Pharmacogenetics; 1999 Jun; 9(3):377-88. PubMed ID: 10471070
[TBL] [Abstract][Full Text] [Related]
30. A comparison of the inhibitory effects of four volatile anaesthetics on the metabolism of chlorzoxazone, a substrate for CYP2E1, in rabbits.
Tateishi T; Watanabe M; Nakura H; Tanaka M; Kumai T; Aoki T; Kobayashi S
Acta Anaesthesiol Scand; 1998 Oct; 42(9):1028-32. PubMed ID: 9809083
[TBL] [Abstract][Full Text] [Related]
31. Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species.
Court MH; Von Moltke LL; Shader RI; Greenblatt DJ
Biopharm Drug Dispos; 1997 Apr; 18(3):213-26. PubMed ID: 9113344
[TBL] [Abstract][Full Text] [Related]
32. Time-dependent effects of Klebsiella pneumoniae endotoxin on the pharmacokinetics of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, in rats: restoration of the parameters in 96 hour in KPLPS rats to control levels.
Jung HY; Kang HE; Choi YH; Kim SH; Lee MG
Biopharm Drug Dispos; 2009 Nov; 30(8):485-93. PubMed ID: 19753555
[TBL] [Abstract][Full Text] [Related]
33. In vivo CYP2E1 phenotyping as a new potential biomarker of occupational and experimental exposure to benzene.
Piccoli P; Carrieri M; Padovano L; Di Mare M; Bartolucci GB; Fracasso ME; Lepera JS; Manno M
Toxicol Lett; 2010 Jan; 192(1):29-33. PubMed ID: 19900514
[TBL] [Abstract][Full Text] [Related]
34. Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity.
O'Shea D; Davis SN; Kim RB; Wilkinson GR
Clin Pharmacol Ther; 1994 Oct; 56(4):359-67. PubMed ID: 7955797
[TBL] [Abstract][Full Text] [Related]
35. Differential induction of ethanol-metabolizing CYP2E1 and nicotine-metabolizing CYP2B1/2 in rat liver by chronic nicotine treatment and voluntary ethanol intake.
Yue J; Khokhar J; Miksys S; Tyndale RF
Eur J Pharmacol; 2009 May; 609(1-3):88-95. PubMed ID: 19285975
[TBL] [Abstract][Full Text] [Related]
36. Effect of piperine on CYP2E1 enzyme activity of chlorzoxazone in healthy volunteers.
Bedada SK; Boga PK
Xenobiotica; 2017 Dec; 47(12):1035-1041. PubMed ID: 27670974
[TBL] [Abstract][Full Text] [Related]
37. Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity.
Raucy JL; Schultz ED; Wester MR; Arora S; Johnston DE; Omdahl JL; Carpenter SP
Drug Metab Dispos; 1997 Dec; 25(12):1429-35. PubMed ID: 9394034
[TBL] [Abstract][Full Text] [Related]
38. Ethanol-mediated transplacental induction of CYP2E1 in fetal rat liver.
Carpenter SP; Savage DD; Schultz ED; Raucy JL
J Pharmacol Exp Ther; 1997 Aug; 282(2):1028-36. PubMed ID: 9262372
[TBL] [Abstract][Full Text] [Related]
39. Ethanol self-administration and nicotine treatment induce brain levels of CYP2B6 and CYP2E1 in African green monkeys.
Ferguson CS; Miksys S; Palmour RM; Tyndale RF
Neuropharmacology; 2013 Sep; 72():74-81. PubMed ID: 23639433
[TBL] [Abstract][Full Text] [Related]
40. Effect of 1-aminobenzotriazole on the in vitro metabolism and single-dose pharmacokinetics of chlorzoxazone, a selective CYP2E1 substrate in Wistar rats.
Muzeeb S; Pasha MK; Basha SJ; Mullangi R; Srinivas NR
Xenobiotica; 2005 Aug; 35(8):825-38. PubMed ID: 16278194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
